Filing Details
- Accession Number:
- 0002001011-25-000037
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-06-02 20:06:06
- Reporting Period:
- 2024-08-10
- Filing Date:
- 2025-06-02
- Accepted Time:
- 2025-06-02 20:06:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 886163 | Ligand Pharmaceuticals Inc | LGND | Pharmaceutical Preparations (2834) | 770160744 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1950232 | Andrew Reardon | 555 Heritage Drive Suite 200 Jupiter FL 33458 | Clo & Secretary | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-08-10 | 897 | $100.16 | 21,637 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2025-05-15 | 1,000 | $104.00 | 32,903 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Footnotes
- Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units.
- The total includes 17 shares acquired on December 31, 2024, through the Issuer's Employee Stock Purchase Plan.
Billionaire Hedge Funds
